Logo-jnp
J Nephropathol. 2012;1(3): 162-163. doi: 10.5812/nephropathol.8113
PMID: 24475409        PMCID: PMC3886151

Commentary

Epidemiology of chronic kidney disease in children

Jameela Kari 1 *

Cited by CrossRef: 19


1- Nasri H. C-Phycocyanin attenuates cisplatin-induced nephrotoxicity in mice. Renal Failure. 2013;35(7):1054 [Crossref]
2- Rafieian-Kopaei M, Nasri H. The Ameliorative Effect of Zingiber officinale in Diabetic Nephropathy. Iran Red Crescent Med J. 2014;16(5) [Crossref]
3- Swathi P, Laxmi P. ASSOCIATION OF SERUM URIC ACID WITH ATHEROGENIC INDEX OF PLASMA AND FASTING BLOOD SUGAR IN METABOLIC SYNDROME AMONG DIABETIC AND NON DIABETICS. ijsr. 2022;:16 [Crossref]
4- Kang H, Ha I, Cheong H. Recurrence and Treatment after Renal Transplantation in Children with FSGS. BioMed Research International. 2016;2016:1 [Crossref]
5- Yogi J, Semar A. Association of Hyperuricemia and Urinary Albumin Excretion with Glycosylated Hemoglobin in Patients with Type II Diabetes Mellitus. 2017;2(1):1 [Crossref]
6- Nematbakhsh M, Nasri H. Cisplatin nephrotoxicity may be sex related. Kidney International. 2013;83(6):1201 [Crossref]
7- Chen L, Wu J, Ying D, Jiang M, Xu Y, Mo Y, Rong L, Jiang X. Application of adrenocorticotropic hormone in recurrent focal segmental glomerulosclerosis postā€transplantation: A case report and literature review. Pediatric Transplantation. 2022;26(2) [Crossref]
8- Mashat S, El-Desoky S, Abdulaziz Kari J. Outcome of Multi-Cystic Dysplastic Kidneys in Children. Iran J Pediatr. 2015;25(5) [Crossref]
9- Nasri H. Helicobacter pylori and Serum Magnesium Level in Hemodialysis Patients. Jundishapur J Microbiol. 2014;7(2) [Crossref]
10- Nasri H. Re Metformin revisited: A critical review of the benefitā€“risk balance in at-risk patients with type 2 diabetes. Diabetes & Metabolism. 2013;39(4):375 [Crossref]
11- Rafieian Kopaei M, Baradaran A. Protective Effects of Metformin on Renal Tubular Cells. Iran Red Crescent Med J. 2014;16(9) [Crossref]
12- Nasri H. Thrombotic Microangiopathy in IgA Nephropathy. Iran Red Crescent Med J. 2013;15(12) [Crossref]
13- Rafieian-Kopaie M, Nasri H. R: Recombinant human erythropoietin reduces rhabdomyolysis-induced acute renal failure in rats. Injury. 2013;44(11):1662 [Crossref]
14- Dai L, Li J, Xie L, Wang W, Lu Y, Xie M, Huang J, Shen K, Yang H, Pei C, Zhao Y, Zhang W. A Biallelic Frameshift Mutation in Nephronectin Causes Bilateral Renal Agenesis in Humans. JASN. 2021;32(8):1871 [Crossref]
15- Ghelichi-Ghojogh M, Mohammadizadeh F, Jafari F, Vali M, Jahanian S, Mohammadi M, Jafari A, Khezri R, Nikbakht H, Daliri M, Rajabi A. The global survival rate of graft and patient in kidney transplantation of children: a systematic review and meta-analysis. BMC Pediatr. 2022;22(1) [Crossref]
16- Yazdani M, Yazdani A, Noori-Mahdavi K, Kabiri M, Baradaran S, Nasri H. Serum and 24-Hour Urinary Uric Acid Levels in Patients with Urolithiasis. Shiraz E-Med J. 2015;16(2) [Crossref]
17- Khalid R, Van Zwieten A, Kim S, Didsbury M, Francis A, Mctaggart S, Walker A, Mackie F, Prestidge C, Teixeira-Pinto A, Barton B, Lorenzo J, Lah S, Howard K, Nassar N, Au E, Tong A, Blazek K, Craig J, Wong G. Association between socioeconomic status and academic performance in children and adolescents with chronic kidney disease. Pediatr Nephrol. 2022;37(12):3195 [Crossref]
18- Nasri R. Renoprotective effects of metformin. DARU J Pharm Sci. 2013;21(1) [Crossref]
19- Zhang L, Zhai S, Zhao L, Zhang Y, Sun B, Ma Q. New PAX2 heterozygous mutation in a child with chronic kidney disease: a case report and review of the literature. BMC Nephrol. 2018;19(1) [Crossref]